PCVX Exercise Disclosure
Wassil Jim · SEC Form 4 · Filed Nov 4, 2026
Exercise
Calculated transaction value
$0
Wassil Jim EVP, Chief Scientific Ofc, COO
PCVX
Vaxcyte
PCVX
Transaction date
Nov 2, 2026
Public filing date
Nov 4, 2026
Filing lag
Filed 2 days later
PCVX daily price context
Close on/before transaction
$60.62
Nov 2, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (right to buy) on Common Stock
- Quantity / price
- 2,250 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001813798-26-000025
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$149.06K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Vaxcyte, Inc. PCVX | Exercise | Nov 2, 2026 | $12.04K |
| Vaxcyte, Inc. PCVX | Sale | Nov 2, 2026 | $115.91K |
| Vaxcyte, Inc. PCVX | Sale | Nov 2, 2026 | $21.12K |
| Vaxcyte, Inc. PCVX Current | Exercise | Nov 2, 2026 | $0 |